Cancer News
Many cancer patients face mental problems
The majority of cancer patients deal with mental disorders. Scientists now highlight the necessity of psychological support additional to treatment.
Stereotactic body radiotherapy prolongs survival in lung cancer patients
Stereotactic body radiotherapy (SBRT) can improve outcomes in patients with non-small cell lung cancer (NSCLC), according to new research.
Early palliative care benefits patients with incurable cancers
Early palliative care improved the quality of life of patients with incurable cancer, lowering levels of depression, according to researchers.
Cancer caregiving is more demanding compared to other conditions
A new study reveals that cancer caregivers face more stress and depression compared to other caregivers.
Everolimus and bevacizumab against non-clear cell renal carcinoma
Patients with advanced non-clear cell renal cell carcinoma (ncRCC) benefited from the combination treatment of everolimus and bevacizumab, researchers report.
Complete response for lymphoma patients with T-cell therapy
Advanced non-Hodgkin lymphoma ((NHL) patients receiving T-cell treatment, JCAR014 and chemotherapy had a complete response, new data show.
Novel drugs expand treatment options for ALL patients
Key findings of the studies including ofatumumab, ponatinib, liposomal vincristine and reduced-intensity therapy for the treatment of ALL patients.
Updates on therapy options for older AML & CLL patients
Promising results from treatment options for older patients with acute myelogenous leukemia (AML) and chronic lymphocytic leukemia (CLL).
Robotic surgery gives hope to oropharyngeal cancer patients
Oropharyngeal cancer patients may avoid significant pain and disfigurement if treated with incisionless robotic surgery, a new study shows.
Poor pain control for many terminal cancer patients
Many terminal cancer patients receive their pain relief drug prescription too late, a new research reveals.
Is joint decision making crucial for prostate cancer patients?
A randomized trial proved the importance of joint decision making between prostate cancer patients and physicians during the treatment selection process.
Neoadjuvant therapy versus upfront surgery for pancreatic cancer
Neoadjuvant chemotherapy followed by surgery led to better outcomes in pancreatic cancer compared to upfront surgery with or without adjuvant chemotherapy.
Recommendations on post-mastectomy RT in breast cancer
An expert panel issued recommendations on post-mastectomy radiation therapy for breast cancer patients, calling for careful counseling and clinical judgement.
Pediatric cancer: dexrazoxane against chemo-related heart damage
The cardioprotective drug dexrazoxane may prevent the chemotherapy-related heart damage of children with cancer treated with anthracyclines, data reveal.
Brain metastasis in lung cancer: is brain radiotherapy beneficial?
Similar quality of life for lung cancer patients with brain metastasis treated with whole brain radiotherapy compared to those who didn’t, an analysis shows.
Apixaban shows promise for atrial fibrillation cancer patients
Cancer patients treated with apixaban saw a 70% reduction in the composite endpoint of stroke, new findings show.
Unravelling the chemo brain: how long does it last?
Half of female breast cancer survivors may suffer from chemo brain, a genuine consequence of chemotherapy. Study tries to find how long it is likely to last.
Venetoclax promising for acute myelogenous leukemia
Venetoclax induced promising outcomes to acute myelogenous leukemia patients whose disease had relapsed or was resistant to chemotherapy, a trial shows.
Comparing robotic vs. non-robotic surgery for prostate cancer
Prostate cancer patients undergoing robotic surgery experienced similar quality of life compared to those undergoing open surgery, a trial reveals.
How obesity & smoking influence cardiotoxicity in breast cancer
Obesity and smoking were associated with higher risk of developing cardiotoxicity after treatment in breast cancer patients, clinical studies reveal.
Stereotactic radiosurgery: better for metastatic brain cancer
Metastatic brain cancer patients treated with stereotactic radiosurgery had less cognitive deterioration three months after treatment, a study finds.
Ipilimumab with local treatments improved survival in melanoma
Adding local peripheral treatments to systemic ipilimumab increased survival in melanoma patients, a retrospective analysis shows.
Active surveillance in advanced kidney cancer. Is it possible?
A study reveals that some adult advanced kidney cancer patients may safely opt for an active surveillance scheme instead of aggressive treatments.
US approves pembrolizumab for squamous cell carcinoma
US regulators approved pembrolizumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma.
Radical treatment increased survival in prostate cancer patients
Very high-risk prostate cancer patients treated with a high proportion of radical local treatment survived longer, according to a new study.
Mantle cell lymphoma: lenalidomide gets EU approval
REVLIMID® (lenalidomide) received approval by the European Commission for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.
Hodgkin lymphoma: closer to cure with immunotherapy
Hodgkin lymphoma patients remained disease-free for over five years after being treated with the immunotherapy brentuximab vedotin, new data shows.
EU regulator backs lenvatinib and everolimus for kidney cancer
Lenvatinib combined with everolimus received a positive opinion by the EU regulator for the treatment of adult patients with advanced renal cell carcinoma.
Choosing treatments for head and neck squamous cell carcinoma
Treatment’s impact on quality of life should be considered when choosing treatment for head and neck squamous cell carcinoma, an analysis shows.
FDA approves molecular diagnostic for chronic myeloid leukemia
US regulator approved the marketing of a molecular diagnostic test measuring BCR-ABL levels in patients with chronic myeloid leukemia (CML).